This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • An open-label study to evaluate biomarkers and saf...
Clinical trial

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with ABR-215757 (paquinimod)

Read time: 1 mins
Last updated:26th Sep 2011
To study changes in disease related biomarkers in patients with progressive SSc during treatment with ABR-215757
Category Value
Study start date 2011-09-26

View full details